MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1

Brain Research Bulletin

Volumn 88, Issue 6, 2012, Pages 596-601

  Zhu, Hong Can ^a   Wang, Li Mei ^a   Wang, Miao ^a   Song, Bo ^a   Tan, Song ^a   Teng, Jun Fang ^a   Duan, Dong Xiao ^b  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Alzheimer's disease; BACE1; MicroRNA; MiR 195

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE 1; MICRORNA; MICRORNA 195; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; BIOINFORMATICS; CELL STRAIN HEK293; DOWN REGULATION; EMBRYO; GENE OVEREXPRESSION; HUMAN; HUMAN CELL CULTURE; IN VITRO STUDY; MOUSE; NEUROFIBRILLARY TANGLE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM;

3' UNTRANSLATED REGIONS; AGING, PREMATURE; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; BINDING SITES; CELL LINE, TUMOR; DOWN-REGULATION; HEK293 CELLS; HIPPOCAMPUS; HUMANS; MICE; MICE, NEUROLOGIC MUTANTS; MICRORNAS; MUTAGENESIS, SITE-DIRECTED; NEUROBLASTOMA; PROTEIN BIOSYNTHESIS; PROTEIN INTERACTION MAPPING; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT FUSION PROTEINS; RNA STABILITY; RNA, MESSENGER;

EID: 84864083653     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2012.05.018     Document Type: Article

References (37)

1. Boissonneault V., Plante I., Rivest S., Provost P. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. Journal of Biological Chemistry 2009, 284:1971-1981.
2. Canudas A.M., Gutierrez-Cuesta J., Rodriguez M.I., Acuna-Castroviejo D., Sureda F.X., Camins A., Pallas M. Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM). Mechanisms of Ageing and Development 2005, 126:1300-1304.
3. Chen K., Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nature Reviews Genetics 2007, 8:93-103.
4. Cheng L.C., Pastrana E., Tavazoie M., Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nature Neuroscience 2009, 12:399-408.
5. Coulson D.T., Beyer N., Quinn J.G., Brockbank S., Hellemans J., Irvine G.B., Ravid R., Johnston J.A. BACE1 mRNA expression in Alzheimer's disease postmortem brain tissue. Journal of Alzheimer's Disease 2010, 22:1111-1122.
6. Del Valle J., Duran-Vilaregut J., Manich G., Casadesus G., Smith M.A., Camins A., Pallas M., Pelegri C., Vilaplana J. Early amyloid accumulation in the hippocampus of SAMP8 mice. Journal of Alzheimer's Disease 2010, 19:1303-1315.
7. Evin G., Lessene G., Wilkins S. BACE inhibitors as potential drugs for the treatment of Alzheimer's disease: focus on bioactivity. Recent Patents on CNS Drug Discovery 2011, 6:91-106.
8. Farr S.A., Price T.O., Dominguez L.J., Motisi A., Saiano F., Niehoff M.L., Morley J.E., Banks W.A., Ercal N., Barbagallo M. Extra virgin olive oil improves learning and memory in SAMP8 mice. Journal of Alzheimer's Disease 2011, 28:81-92.
9. Haass C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nature Reviews Molecular Cell Biology 2007, 8:101-112.
10. Harada H., Tamaoka A., Ishii K., Shoji S., Kametaka S., Kametani F., Saito Y., Murayama S. Beta-site APP cleaving enzyme 1 (BACE1) is increased in remaining neurons in Alzheimer's disease brains. Neuroscience Research 2006, 54:24-29.
11. Hebert S.S., Horre K., Nicolai L., Papadopoulou A.S., Mandemakers W., Silahtaroglu A.N., Kauppinen S., Delacourte A., De Strooper B. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:6415-6420.
12. Holsinger R.M., McLean C.A., Beyreuther K., Masters C.L., Evin G. Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease. Annals of Neurology 2002, 51:783-786.
13. Iqbal K., Liu F., Gong C.X., Grundke-Iqbal I. Tau in Alzheimer disease and related tauopathies. Current Alzheimer Research 2010, 7:656-664.
14. Kim V.N. MicroRNA biogenesis: coordinated cropping and dicing. Nature Reviews Molecular Cell Biology 2005, 6:376-385.
15. Kocerha J., Faghihi M.A., Lopez-Toledano M.A., Huang J., Ramsey A.J., Caron M.G., Sales N., Willoughby D., Elmen J., Hansen H.F., Orum H., Kauppinen S., Kenny P.J., Wahlestedt C. MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:3507-3512.
16. Kumar V.B., Franko M., Banks W.A., Kasinadhuni P., Farr S.A., Vyas K., Choudhuri V., Morley J.E. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing. Journal of Experimental Biology 2009, 212:494-498.
17. Li R., Lindholm K., Yang L.B., Yue X., Citron M., Yan R., Beach T., Sue L., Sabbagh M., Cai H., Wong P., Price D., Shen Y. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:3632-3637.
18. Liu W., Liu C., Zhu J., Shu P., Yin B., Gong Y., Qiang B., Yuan J., Peng X. MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice. Neurobiology of Aging 2010, 33:522-534.
19. Long J.M., Lahiri D.K. MicroRNA-101 downregulates Alzheimer's amyloid-beta precursor protein levels in human cell cultures and is differentially expressed. Biochemical and Biophysical Research Communications 2010, 404:889-895.
20. Luo X., Yan R. Inhibition of BACE1 for therapeutic use in Alzheimer's disease. International Journal of Clinical and Experimental Pathology 2010, 3:618-628.
21. Magill S.T., Cambronne X.A., Luikart B.W., Lioy D.T., Leighton B.H., Westbrook G.L., Mandel G., Goodman R.H. microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:20382-20387.
22. Manich G., Mercader C., del Valle J., Duran-Vilaregut J., Camins A., Pallas M., Vilaplana J., Pelegri C. Characterization of amyloid-beta granules in the hippocampus of SAMP8 mice. Journal of Alzheimer's Disease 2011, 25:535-546.
23. Morley J.E., Farr S.A., Kumar V.B., Armbrecht H.J. The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer's disease. Current Pharmaceutical Design 2012, 18:1123-1130.
24. Morley J.E., Kumar V.B., Bernardo A.E., Farr S.A., Uezu K., Tumosa N., Flood J.F. Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides 2000, 21:1761-1767.
25. Nunez-Iglesias J., Liu C.C., Morgan T.E., Finch C.E., Zhou X.J. Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PLoS One 2010, 5:e8898.
26. Preece P., Virley D.J., Costandi M., Coombes R., Moss S.J., Mudge A.W., Jazin E., Cairns N.J., Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease. Brain Research. Molecular Brain Research 2003, 116:155-158.
27. Schratt G. microRNAs at the synapse. Nature Reviews Neuroscience 2009, 10:842-849.
28. Schratt G.M., Tuebing F., Nigh E.A., Kane C.G., Sabatini M.E., Kiebler M., Greenberg M.E. A brain-specific microRNA regulates dendritic spine development. Nature 2006, 439:283-289.
29. Shioya M., Obayashi S., Tabunoki H., Arima K., Saito Y., Ishida T., Satoh J. Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathology and Applied Neurobiology 2010, 36:320-330.
30. Takeda T., Hosokawa M., Higuchi K. Senescence-accelerated mouse (SAM): a novel murine model of accelerated senescence. Journal of the American Geriatrics Society 1991, 39:911-919.
31. Vetrivel K.S., Barman A., Chen Y., Nguyen P.D., Wagner S.L., Prabhakar R., Thinakaran G. Loss of cleavage at beta'-site contributes to apparent increase in beta-amyloid peptide (Abeta) secretion by beta-secretase (BACE1)-glycosylphosphatidylinositol (GPI) processing of amyloid precursor protein. Journal of Biological Chemistry 2011, 286:26166-26177.
32. Wang W.X., Rajeev B.W., Stromberg A.J., Ren N., Tang G., Huang Q., Rigoutsos I., Nelson P.T. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. Journal of Neuroscience 2008, 28:1213-1223.
33. Woodruff-Pak D.S. Animal models of Alzheimer's disease: therapeutic implications. Journal of Alzheimer's Disease 2008, 15:507-521.
34. Xu T., Zhu Y., Xiong Y., Ge Y.Y., Yun J.P., Zhuang S.M. MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 2009, 50:113-121.
35. Yang L.B., Lindholm K., Yan R., Citron M., Xia W., Yang X.L., Beach T., Sue L., Wong P., Price D., Li R., Shen Y. Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nature Medicine 2003, 9:3-4.
36. Zhang Y.C., Wang Z.F., Wang Q., Wang Y.P., Wang J.Z. Melatonin attenuates beta-amyloid-induced inhibition of neurofilament expression. Acta Pharmacologica Sinica 2004, 25:447-451.
37. Zhao C., Sun G., Li S., Lang M.F., Yang S., Li W., Shi Y. MicroRNA let-7b regulates neural stem cell proliferation and differentiation by targeting nuclear receptor TLX signaling. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:1876-1881.